These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22284988)

  • 1. Hormetic effect of amyloid-β peptide in synaptic plasticity and memory.
    Puzzo D; Privitera L; Palmeri A
    Neurobiol Aging; 2012 Jul; 33(7):1484.e15-24. PubMed ID: 22284988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective impairment of some forms of synaptic plasticity by oligomeric amyloid-β peptide in the mouse hippocampus: implication of extrasynaptic NMDA receptors.
    Kervern M; Angeli A; Nicole O; Léveillé F; Parent B; Villette V; Buisson A; Dutar P
    J Alzheimers Dis; 2012; 32(1):183-96. PubMed ID: 22785392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The γ-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice.
    Balducci C; Mehdawy B; Mare L; Giuliani A; Lorenzini L; Sivilia S; Giardino L; Calzà L; Lanzillotta A; Sarnico I; Pizzi M; Usiello A; Viscomi AR; Ottonello S; Villetti G; Imbimbo BP; Nisticò G; Forloni G; Nisticò R
    J Alzheimers Dis; 2011; 24(4):799-816. PubMed ID: 21321397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition.
    Kroker KS; Mathis C; Marti A; Cassel JC; Rosenbrock H; Dorner-Ciossek C
    Neurobiol Aging; 2014 Sep; 35(9):2072-8. PubMed ID: 24746365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic effects of oligomeric Aβ(1-42) on hippocampal synaptic plasticity in vivo].
    Tan T; Zhang BL; Tian X
    Sheng Li Xue Bao; 2011 Jun; 63(3):225-32. PubMed ID: 21681340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormesis and amyloid-β protein: physiology or pathology?
    Morley JE; Farr SA
    J Alzheimers Dis; 2012; 29(3):487-92. PubMed ID: 22258515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
    Rowan MJ; Klyubin I; Wang Q; Anwyl R
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):563-7. PubMed ID: 16042545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin-1 prevents amyloid β-induced impairment of long-term potentiation in hippocampal slices via ErbB4.
    Min SS; An J; Lee JH; Seol GH; Im JH; Kim HS; Baik TK; Woo RS
    Neurosci Lett; 2011 Nov; 505(1):6-9. PubMed ID: 21787838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
    Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo.
    Hu NW; Smith IM; Walsh DM; Rowan MJ
    Brain; 2008 Sep; 131(Pt 9):2414-24. PubMed ID: 18678563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
    Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
    Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons.
    Nomura I; Kato N; Kita T; Takechi H
    Neurosci Lett; 2005 Dec; 391(1-2):1-6. PubMed ID: 16154266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of amyloid β-protein on hippocampal long-term potentiation].
    Zhang JF; Yang D; Qi JS
    Sheng Li Xue Bao; 2010 Dec; 62(6):479-88. PubMed ID: 21170492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
    Jing W; Guo F; Cheng L; Zhang JF; Qi JS
    Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case for a non-transgenic animal model of Alzheimer's disease.
    Stéphan A; Phillips AG
    Genes Brain Behav; 2005 Apr; 4(3):157-72. PubMed ID: 15810904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of α7 nicotinic acetylcholine receptors for amyloid β protein-induced depression of hippocampal long-term potentiation in CA1 region of rats in vivo.
    Li SF; Wu MN; Wang XH; Yuan L; Yang D; Qi JS
    Synapse; 2011 Nov; 65(11):1136-43. PubMed ID: 21584864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-beta at sublethal level impairs BDNF-induced arc expression in cortical neurons.
    Wang DC; Chen SS; Lee YC; Chen TJ
    Neurosci Lett; 2006 May; 398(1-2):78-82. PubMed ID: 16412575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic psychosocial stress accelerates impairment of long-term memory and late-phase long-term potentiation in an at-risk model of Alzheimer's disease.
    Tran TT; Srivareerat M; Alkadhi KA
    Hippocampus; 2011 Jul; 21(7):724-32. PubMed ID: 20865724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.